Bipolar Disorder 2nd Edition, Advances in Psychotherapy
4.6 out of 5.0, Based on: 390 reviews
Course Summary
This course provides an extensively updated new edition of the acclaimed guide to treatment
of bipolar disorder, incorporating the latest research on psychosocialtreatments and clear medication
management guidelines. This extensively updated new edition of the acclaimed book in the Advances
in Psychotherapy series integrates empirical research from the last 10 years to provide clear and
up-to-date guidance on the assessment and effective treatment of bipolar disorder. The course begins
by describing the main features of bipolar disorder based on DSM-5 and ICD-10 criteria. Current theories
and medication management guidelines are described, along with decision trees for evaluating the
best treatment options. They then outline a systematic, integrated, and empirically supported treatment
approach involving structured, directive therapy. Special considerations, including managing suicide
risk, substance misuse, and medication nonadherence, are also addressed.
Course Format
This course is based on a book and a post test. When you're ready, purchase the test by clicking the "Add To Cart" button. This will let you take the test and receive your certificate for CE credits.
Learning Objectives
- Identify the incidence of Bipolar Disorder.
- Describe the differential diagnosis of Bipolar 1 and II.
- Explain the assessment of Bipolar Disorder.
- Describe medications used to treat Bipolar Disorder.
Course Syllabus
- Description of Bipolar Disorder
- Theories and Models of Bipolar Disorder
- Diagnosis and Treatment Indications
- Treatment
Counselors:
Ce4Less.com has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6991. Programs that do not qualify for NBCC credit are clearly identified. Ce4Less.com is solely responsible for all aspects of the programs.
We are committed to providing our learners with unbiased information. CE4Less never accepts commercial support and our authors have no significant financial or other conflicts of interest pertaining to the material